The cost-effectiveness of rosacea treatments.

Thomas K, Yelverton CB, Yentzer BA, Balkrishnan R, Fleischer AB, Feldman SR. The cost-effectiveness of rosacea treatments. J Dermatolog Treat. 2009; 20(2):72-5.

View in: PubMed

subject areas

Administration, Oral
Administration, Topical
Anti-Bacterial Agents
Anti-Inflammatory Agents
Clinical Trials as Topic
Cost of Illness
Cost Savings
Cost-Benefit Analysis
Drug Administration Schedule
Drug Costs
Drug Therapy, Combination
Female
Humans
Male
Metronidazole
Rosacea
Time Factors
United States

authors with profiles

Steven R. Feldman MD, PhD